Viral entry and the development of vaccines.

病毒进入和疫苗的开发。

• 批准号: nhmrc : GNT1041897
• 负责人: A/Pr Heidi Drummer
• 金额: $ 66.58万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/viral-entry-development-vaccines/1344387
• 关键词: Viral; entry; development; vaccines.

Hepatitis C virus (HCV) and Human immunodeficiency virus (HIV) infect 200 million and 50 million people world-wide, respectively, and there are no preventative vaccines. The work outlined in this fellowship seeks to understand the structure and function of the major surface proteins of these viruses, their ability to be recognised by the immune system and to develop a novel vaccine for the prevention of HCV.

丙型肝炎病毒（HCV）和人类免疫缺陷病毒（HIV）分别感染全球2亿和5000万人，并且没有预防性疫苗。这项研究概述的工作旨在了解这些病毒的主要表面蛋白的结构和功能，它们被免疫系统识别的能力，以及开发预防HCV的新型疫苗。